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Abstract  
We present a simple and rapid method for the synthesis of small magnetic nanoparticles 
(diameters in the order of 5-20 nm) and narrow size distributions (CV’s of 20-40%). The 
magnetite nanoparticles were synthesized in green solvents within minutes and the saturation 
magnetization of the particles was tunable by changes in the reaction conditions. We show that 
this particle synthesis method requires minimal processing steps and we present the successful 
coating of the particles with reactive bisphosphonates after synthesis without washing or 
centrifugation. We found minimal batch-to-batch variability and show the scalability of the 
particle synthesis method. We present a full characterization of the particle properties and 
believe that this synthesis method holds great promise for facile and rapid generation of magnetic 
nanoparticles with defined surface coatings for magnetic targeting applications. 
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Introduction 
Drug delivery is an important method in the fight against cancer and other diseases as it increases 
specificity between the target site and the drug, thereby lowering side effects due to whole body 
drug exposure. Different vectors that interact with a target site in the body (e.g., an inflamed 
tissue) can facilitate drug delivery. Magnetic nanoparticles (MNPs) can be used as such vectors 
and can be guided and enriched at the target site by directed magnetic fields [1]. Magnetic drug 
targeting is a recent drug delivery method where the drug is bound to the MNPs and, after 
delivery to the target, is released to induce a therapeutic effect [2]. Different factors can impact 
the quality of the magnetic drug carrier, which include its size distribution and composition, its 
cell permeability and especially its protective coating and release characteristics of the bound 
drug. A major challenge in the development of magnetic drug carriers for clinical therapy has 
been the poor particle size distribution of MNPs, methods producing large amounts of particles 
per batch, and the poor mass throughput of methods producing MNPs with excellent size 
distributions [3]. In addition, the protective coating of the MNPs needs to be multifunctional; that 
is it needs to be a thin biocompatible coating and it needs to facilitate peptide and antibody 
conjugation, as well as encapsulate/bind and controllably release a drug. 
Conventional methods to synthesize MNPs that have high yields include microemulsion 
syntheses [4] and wet chemical methods based on iron salt solutions through co-precipitation or 
thermal decomposition from organometallic solvent solutions [5,6]. The latter method has gained 
attraction as a fast synthetic strategy to create uniform MNPs, but requires high temperatures, 
toxic chemicals, and the addition of stabilizing agents [7–10]. Over the past years, solvothermal 
synthetic strategies have been studied in detail [11], particularly with a focus on low cost 
precursor materials including iron pentacarbonyl [7], iron oleate [12], iron(II) acetate [9], and 
iron(III) acetylacetonate [8]. The main advantage of solvothermal synthesis is the high level of 
control over the reaction conditions. But the use of toxic and combustible solvents (e.g., benzyl 
ethers or octadecene) limits the application of particles created by this method. The use of these 
particles in biological applications such as magnetic drug targeting requires extensive post-
processing to separate the MNPs from toxic solvents and residual stabilizing agents, and it often 
requires further wet chemical methods to create biocompatible and functional coatings. All these 
steps increase the time required to create functionalized and biocompatible MNPs. In addition, 
the use of different solvents for MNP synthesis and subsequent coating can create challenges in 
terms of solubility mismatches between MNPs and coating materials, changes in colloidal 
stability of the particles, and low yield of the final coated biocompatible MNPs. To overcome 
these limitations and increase the versatility and applicability of MNPs as magnetic drug carriers 
in in vivo applications, it is desirable to take advantage of the wealth of available methods for 
particle synthesis and to minimize the overall processing steps (i.e., reduction in centrifugation 
and washing steps), thereby creating a one-pot synthetic method with high control over the 
particle quality, high yield, and high mass throughput per particle batch. 
Recent advances in novel microwave-based synthetic methods [13–15] provide the foundation to 
design simplified synthetic strategies that take advantage of isochoric reaction conditions and so 
called greener solvents. Greener solvents are less toxic, produce fewer harmful byproducts, and 
are favorable in synthetic chemical methods aimed at biological applications. Among the greener 
solvents are dihydroxy alcohols, including triethylene glycol (TEG), whose physicochemical 
properties are favorable for solvothermal decomposition methods (i.e., high viscosities and 
boiling points). TEG is typically used as a plasticizer [16] as well as a dehydration solvent in the 
gas industry [17]. It is also known to be a mild disinfectant and shows no known toxicities unlike 
the related di(ethylene glycol) [18,19]. In addition, its high solubility in water is ideal to simplify 
sample post-processing steps. Other alcohols suitable for solvothermal decomposition due to 
their high viscosities and boiling points include benzyl alcohol, which is immiscible in water. 
Synthesis of MNPs with benzyl alcohol and triethylene glycol as solvents has been shown to 
yield uniform MNPs in autoclaves [20–23] and by microwave-based methods [24,25]. However, 
all these methods required several processing steps followed by multiple washing and (often) 
centrifugation steps to separate the MNPs from the solvents. Microwave based MNP synthesis 
was also shown from aqueous Fe
2+
 and Fe
3+
, resulting in -Fe2O3 and -Fe2O3 MNPs [26,27], 
which exhibit lower saturation magnetization than Fe3O4. 
Here we present a fast method to produce large quantities of functionalized MNPs for the use as 
magnetic drug carrier precursors with excellent size distributions by a combination of facile 
microwave synthesis and a bisphosphonate coating strategy. The bisphosphonate coating 
provides an active amine group for conventional amine-reactive crosslinker chemistry [28], 
which is ideal for functional bioconjugation to cell permeable proteins, antibodies, and drugs. 
The particles created by this one-pot synthetic method are uniform in size and shape, water 
soluble, and contain mainly magnetite, as supported by full particle characterization. 
 
Materials and Methods 
Particle Synthesis & Coating 
Microwave synthesis experiments were conducted in an Initiator
+
 (Biotage Sweden AB, 
Uppsala, Sweden). All experiments were conducted with a solution of iron acetylacetonate 
(Fe(acac)3; Fe(C5H7O2)3; cat. F300; Sigma Aldrich Ltd., Oakville, ON, Canada) in tri(ethylene 
glycol) (cat. #T59455, Sigma Aldrich) under inert conditions. Prior to the synthesis, the 
Fe(acac)3 was mixed in Biotage microwave vials together with the solvent and sealed with vial 
caps. Typical reaction volumes were 2 mL, but larger reaction volumes (up to 20 mL) were used 
in scale-up studies.  
A customized N2 – flood system was used to blanket the solution with N2 for 30 min (Fig. 1). 
The Fe(acac)3 was then converted into magnetic nanoparticles through thermal decomposition in 
the Initiator
+
 by first heating to 200°C for up to 24 h (th) followed by reflux heating to 250°C for 
up to 24 h (trf). The total reaction time is given as the sum of th, trf, and the time used for heating 
and cooling to the pre-set temperatures (typically 5-10 min).  
 
Figure 1. General process flow in the particle synthesis: (i) The precursor iron salt is dissolved 
under inert conditions, (ii) undergoes thermal decomposition in a microwave oven resulting in 
the formation of nanoparticles, (iii) which are coated directly in the reaction vessel (one pot 
method). Subsequent precipitation and separation/washing using a magnet or centrifuge yields 
stable water-soluble particles. 
 
The particles were coated directly in the microwave vials by injecting alendronic acid (cat. 
#A2120, 98% pure; TCI America, Portland, OR, USA) through the vial cap’s occulum. The 
alendronic acid solution was prepared fresh the same day of coating in ultrapurified water 
(MilliQ, Millipore Corp., Milford, MA) at a concentration of 5 mg/mL aided by sonication for 60 
min. The particles were then separated and prepared for analysis by precipitation in ethyl 
acetonate, followed by centrifugation at 8,200×g for 10 min. This process was repeated and the 
particles redispersed in water or dried under nitrogen for analysis. 
 
Particle Bioconjugation  
Different stock solutions were prepared on the day of the conjugation. A stock solution of 0.5 M 
MES buffer (2-(N-morpholino) ethanesulfonic acid (MES); cat. # M3671; Sigma Aldrich Ltd.) at 
pH 3-4 was prepared in distilled water. The conjugation buffer consisted of 6 mg/mL EDC (N-
(3-dimethylamino-propyl)-N′-ethylcarbodiimide hydrochloride; cat. # E7750; Sigma Aldrich 
Ltd.) and 12 mg/mL NHS (N-hydroxy-succinimide; cat. # 130672; Sigma Aldrich Ltd.) 
dissolved in MES buffer. A stock solution of 4 mg/mL rhodamine B (cat. # R6626, Sigma 
Aldrich Ltd.) was prepared in MES buffer. 
Alendronate coated magnetic nanoparticles (alendronate-MNPs) were washed twice in ethyl 
acetate and subsequently dried. The particles were then resuspended in ultra purified water (18.2 
MΩ; MilliQ; Millipore Corp.) to achieve a concentration of 20 mg/mL and dispersed by 
sonication for 25 min. An aliquot of 1 mg particle dry weight was then mixed with 0.5 mL 
conjugation buffer (10 mg/mL EDC, 20 mg/mL NHS in MES) and 2 mg of rhodamine. The 
mixture was incubated for 30 min on a rotor after which the sample was titrated to pH 7.6 with 5 
M NaOH. After 1 hour incubation the sample was removed from the rotor and dialyzed for 5 
days (Spectra/Por Dialysis Membrane, MWCO 1,000 Da; cat. #132638; Spectrum Labs, Irving, 
TX). Subsequently, the sample was recovered and resuspended in 0.5 mL ultra purified water 
followed by sonication for 5 min. The rhodamine-coated MNPs were washed once in water by 
centrifugation (14,000 rpm, 15 min; Model 5415, Eppendorf AG; Hamburg, Germany), dried, 
and stored until further analysis. 
 
In vitro viability testing by MTT assay 
Pristine magnetic nanoparticles synthesized for 30 min and 48 h were precipitated by acetone, 
washed twice, and dried. The dried particles were re-dispersed into ultrapurified water at a 
concentration of 1 mg/mL and sonicated for 30 min on ice. The re-dispersed samples were 
analyzed by DLS for particle size and Zeta potential (Nano ZS; Malvern Instruments Ltd, 
Worcestershire, UK). Before in vitro testing, the particle samples were sterile filtered (0.22 µm 
Millex
®
GP filter units; Millipore, Billerica, MA, USA). The particles were then diluted with 
culture media before assessment by MTT assay.  
Cell viability MTT assays were conducted to investigate the effect of the particles at different 
concentrations on the viability of cancer cells. Human prostate cancer cells (PC-3; ATCC CRL-
1435TM; American Type Culture Collection, Manassas, VA, USA) and mouse embryo 
fibroblast cells (NIH/3T3; ATCC
®
 Number: CRL-1658TM; ATCC) were cultured in 75 cm
2
 
tissue culture flask (Falcon
TM
; cat.# 430641 Corning Inc., Corning, NY, USA) according to 
protocols provided by the ATCC. The PC-3 cells were subcultured in F-12K Medium (cat. 
#21127022; Invitrogen Corporation; Carlsbad, CA), while the NIH/3T3 cells were subcultured in 
Dulbecco's Modified Eagle's Medium (DMEM; ATCC
®
 Number: 30-2002; ATCC). All media 
were supplemented with 10% fetal bovine serum (FBS; cat. # 12483-020; Invitrogen Corp.) and 
1% Penicillin/Streptomycin (Penicillin-Streptomycin 10,000 units/mL penicillin, 10 mg/mL 
streptomycin; cat. #10378-016; Invitrogen Corp.). The cells were subcultured in an incubator at 
constant humidity, 5% CO2, and 37°C. 
For the MTT assay, the cells were harvested aided by trypsin and resuspended in the required 
volume of culture media. The cell concentration was subsequently evaluated using a 
hemacytometer (AO Spencer Bright-Line, St. Louis, MO). Aliquots of 100 µL cell stock solution 
were transferred into a 96-well plate (Microtest 96; cat. # 353072, BD Bioscience, Bedford, MA) 
giving a seed concentration of 1,250 cells/well. The cells were then cultured for 24 h at constant 
humidity, 5% CO2, and 37°C. After the culture period, 100 µL aliquots of the particle 
suspensions in the respected media were added to the wells without removal of the media in the 
wells and the cells were subsequently incubated with the MNPs for 22 h. The MTT stock 
solution was prepared by dissolving 5 mg/mL thiazolyl blue tetrazolium bromide (cat.# M2128; 
Sigma Aldrich, Inc.) in phosphate buffered saline (1× PBS). The solution was sonicated for 15 
min followed by sterile filtration through a syringe filter. On the final day of the assay, 20 µL of 
the MTT stock solution was added to each well and the 96-well plate was shaken for 30 s on the 
plate reader. The 96-well plates were then incubated at 37°C in an incubator for 3 h. Finally, the 
solution was removed completely from each well and replaced by 150 µL of DMSO, shaken for 
30 s on the plate reader, followed by incubation for 1 h in the dark at room temperature. The 
resulting color change was evaluated at 540 nm using multiscanner (Multiscan Ascent; 
Labsystems, Helsinki, Finland). 
 
Transmission Electron Microscopy 
Transmission Electron Microscopy was conducted on a Hitachi 7600 with an AMT Advantage (1 
megapixel) CCD camera (Hamamatsu ORCA). Small aliquots of the samples were first washed 
twice by precipitation with ethyl acetate and centrifugation at 8,200×g for 10 min. The samples 
were resuspended in chloroform and pipetted onto TEM grids (PELCO
®
 Formvar/Carbon 200 
mesh TH; cat. #01803-F, Ted Pella, Inc., Redding, CA, USA). The particle size and size 
distribution of n > 2,300 particles was then assessed and measured aided by a customized particle 
imaging algorithm (LabVIEW, National Instruments Corporation, Austin, TX, USA). 
 
Dynamic Light Scattering and Zeta Potential 
The particle size distribution and Zeta potential was measured on a Zetasizer Nano ZS (Malvern 
Instruments Ltd, Worcestershire, UK) using acrylic cuvettes (4 mL, square cuvette; cat. #67.755; 
Sarstedt INC, Newton, NC, USA) and folded capillary cells (cat. # DTS1070; Malvern 
Instruments Ltd), respectively. The parameters used for the dynamic light scattering (DLS) 
measurements were nTEG = 1.4559, ηTEG = 49.00 cP, nFeOx = 2.4200, abs. = 0.200. 
The isoelectric points of MNP samples were determined by titration and measuring the 
respective Zeta potentials of the samples. The washed MNP samples were first resuspended in 
ultrapurified water, followed by bath-sonication for 10 min. The samples were titrated using 0.1 
M NaOH and 0.1 M HCl over a range between pH = 2 and 12 (SG2-ELK – SevenGo™ pH 
meter with an InLab
®
 Micro Electrode; Mettler-Toledo Inc., Columbus, OH, USA). All 
measurements were conducted in triplicate (minimum of 10 measurements each). 
 
Fourier Transform – Infrared Spectroscopy 
Fourier Transform – Infrared (FT-IR) spectroscopy was conducted on a Spotlight 400 FTIR 
Imaging System (Perkin Elmer, Waltham, MA, USA). Dry particle samples were measured on 
an Attenuated Total Reflectance (ATR) crystal and the spectra were acquired at a wavenumber 
range from 650 – 4,000 cm-1 and with four (4) cumulative scans at a resolution of 4 cm-1. Finally, 
the spectra were ATR corrected using an algorithm provided by Perkin Elmer. 
 
Magnetic Property Characterization 
Magnetic properties of the samples were measured using a Vibrating Sample Magnetometer 
(VSM; LakeShore 7400 Series, Lake Shore Cryotronics, Inc., Westerville, OH, USA) at room 
temperature. The viscosity of the samples was measured by rheometry (Physica MCR301 
rheometer; Anton Paar USA Inc., Ashland, VA, USA) and used to determine sample density, 
shear flow, saturation magnetization, and particle size distribution based on a method by Weser 
and Stierstadt [29].  
The samples were also characterized using a Superconducting Quantum Interference Device 
(SQUID) Magnetometer. The samples were prepared by impregnating a piece of cotton with a 
small aliquot of particle suspension. The impregnated piece of cotton was then placed in a gelatin 
capsule for magnetic characterization. The field dependent magnetization measurements were 
performed in a MPMS-5S SQUID Magnetometer (Quantum Design Inc., San Diego, CA, USA) 
at 300 K up to 5 T. MNP powders were weighed and digested with nitric acid (1 h at 90 ºC) and 
Inductively Coupled Plasma – Optical Emission Spectrometry (ICP-OES) was used to measure 
the iron content in the samples calibrated against standard solutions in an OPTIME 2100DV 
(Perkin Elmer). 
 
X-Ray Diffraction Analysis 
X-Ray Diffraction (XRD) analysis of dried samples was conducted with Cu radiation on a 
Bruker D8-Advance (Bruker Canada, Milton, ON, CAN) equipped with a LynxEye silicon strip, 
a Ni filter (to strip out the CuKbeta radiation), and Bragg-Brentano configuration. 
 
Differential Scanning Calorimetry 
Thermal properties of the MNPs and MNPs coated with alendronate were investigated by 
Differential Scanning Calorimetry (DSC) analysis on a DSC Q100 (TA Instruments, New Castle, 
DE, USA). The samples were placed in hermetic aluminum pans and heated to 500°C at a rate of 
20°C/min at constant nitrogen flow of 50 mL/min. After a one minute isothermal step, the 
samples were cooled at a rate of 20°C/min. 
 
Results and Discussion 
Synthesis and Particle Size Distribution 
The MNPs synthesized by the microwave-based method presented here in TEG showed small 
sizes and relatively narrow size distributions. We tested different reaction conditions and the 
heating duration was varied to investigate changes in the particles’ properties. Both, TEM 
imaging and Dynamic Light Scattering analysis were used to characterize the particle sizes and 
shapes.  
The particles synthesized by our method are round with irregular shapes as shown by TEM 
imaging (Fig. 2). With increasing duration for the heating and reflux heating, the particle size 
increased from 6.2 ± 1.5 nm (t = 30 min; Fig. 2a) to 12.3 ± 3.4 nm (t = 48.3 h; Fig. 2e) based on 
size analysis of TEM images. The measurements by dynamic light scattering show a larger size 
of the particles (e.g., 9.6 ± 3.6 nm for t = 30 min; Fig. 2f) compared to TEM measurements. This 
was expected as the scattering analysis by the DLS includes the measurement of solvent layers 
adsorbed to the particles, while sizes measured from TEM are only from the iron oxide core. It 
can be seen that with increasing heating durations (th, trf) the particle size increases in the 
measurements by DLS and by TEM, but the increase was found to be stronger in the particles 
measured by DLS with average sizes of up to 24.4 ± 9.1 nm for t = 48.3 h (Fig. 2f). It has to be 
noted that the particle samples for the longest heating duration (t = 48.3 h) showed large clusters 
in the TEM samples (see Fig. 2e) and the image analysis from TEM images with the custom 
particle imaging algorithm was not feasible for this parameter. Instead the particles were 
measured manually for this parameter (n = 250). 
 Figure 2. TEM Images of MNPs synthesized with reaction times of (a) 0.5 h, (b) 1.3 h, (c) 6.3 h, 
(d) 22.3, and (e) 48.3 h. The particle size distributions measured by DLS and TEM (n > 2,300) 
are shown in (f). The scale bars in images (a-e) correspond to 100 nm, while the ones in the 
insets correspond to 10 nm. Biocompatibility test of MNPs in vitro with particles synthesized for 
30 min and 48.3 h are shown for PC-3 cells and NIH/3T3 cells (g). Note that the particle 
concentration is shown on a logarithmic scale after the broken axis. FTIR analysis (h) and 
titrated Zeta potential (i) of pristine MNPs (green), alendronate coated MNPs (red), and 
rhodamine labeled MNPs (purple). 
 
Overall, it was found that the particle size distribution increased slightly with increasing reaction 
time, both in measurements by TEM and DLS. The increase in the particle’s CV’s measured for 
reaction times of t = 30 min to t = 48.3 h was from 24.1% to 39.1% for TEM analysis and from 
35.4% to 37.4% for DLS analysis. The overall batch-to-batch variability was found to be small 
for the same reaction parameters (i.e., heating duration, precursor concentration, reaction 
volume). To further test the scalability of the method we varied the precursor concentration and 
reaction volume, which provides a scaling factor of 500 in terms of mass throughput. We found 
that with increasing precursor concentration from 0.01 M to 0.50 M the particle size became 
more disperse, while the samples showed similar average particle diameters between 7.1 nm to 
8.9 nm (Fig. 3a). 
Moreover, a 10-fold increase in reaction volume showed an increase in particle size distribution 
(Fig. 3b,c). This increase in particle CV was related to fluctuations in the reaction conditions, 
which was caused by fluctuations in the heating of the larger 20 mL vials in the Initiator
+
 when 
compared to 2 mL vials used in most of the studies presented here (graphs in Fig. 3b,c). 
The challenges in heating larger vials are thought to be due to stronger thermal gradients that 
develop within the vials. The temperature of the reaction solution is measured by IR directly at 
the outer glass surface of the vials. We encountered a delay in the respective feed-back control to 
the microwave radiation required to maintain a set temperature in our studies with iron salt 
solutions. Strong fluctuations, however, were only found in experiments with large vials. In 
smaller vials (2 mL), the temperature was maintained by the Initiator
+ 
at or near the pre-set 
temperature for over 48 h. For example, we found that for a pre-set temperature of 250°C the 
temperature varied only by ±2.4°C over 24 h. Aside from the increase in particle dispersity, the 
microwave synthesis method presented here provides the ability for a significant scale-up in 
mass throughput. By both increasing the reaction volume and the precursor concentration, the 
particle throughput can be scaled from a few milligrams to 10’s of grams of MNPs per batch. 
 
Figure 3. Scale up in reaction conditions and the effect on particle size (by TEM): Change in 
precursor concentration (a) and changes on reaction volume (b,c). Graphs in (b,c) show the trace 
of power input, temperature, and pressure in the reaction vial during a typical synthesis. The 
study with changes in precursor concentration were conducted with a sample volume of 2 mL 
and at a total reaction time of 1.3 h. 
 
Biocompatibility 
The effect of the particles’ dispersity and cytotoxicity was investigated by in vitro MTT assays 
with a focus on the toxicity of MNPs synthesized for 30 min and 48.3 h. We found in our study 
no effect on cell viability when pristine MNPs synthesized for 30 min and 48 h were applied in 
vitro to NIH/3T3 and PC-3 cell lines up to a concentration of 100 g Fe / mL (Fig. 2g). The 
toxicological effects of TEG coated MNPs in our study were comparable to similar studies using 
MTT assays in HeLa, U87MG, and HepG2 cell lines [30]. Our MNPs are thus biocompatible at 
concentrations up to at least 100 µg Fe / mL. 
 
FT-IR Analysis & Zeta Potential 
The particles were coated directly in the vial after completion of the synthesis by injecting 
alendronic acid. This one-pot synthesis and coating has the advantage of eliminating time 
intensive washing and purification steps used in conventional methods. FT-IR spectral analysis 
was used to characterize the success of the coating (Fig. 2h). Furthermore, the successful coating 
was also verified by taking advantage of changes in the particle’s Zeta potential due to the 
presence of alendronate on the particle surface (Fig. 2i).  
The FT-IR spectra of pristine MNPs (green line in Fig. 2h) show strong peaks between 1,150 – 
1,040 cm
-1
, which can be attributed to triethylene glycol (TEG), the solvent used for synthesis. In 
addition, structural peaks between 1,500 – 1,250 cm-1, and between 3,500 – 2,800 cm-1 (data not 
shown) indicate the presence of TEG on the particle surface after synthesis. Similar peaks that 
can be associated with the presence of TEG are found in the spectra of alendronate coated 
MNPs, indicating residual TEG on the particles after washing in ethyl acetate (red line in Fig. 
2h). This is in good agreement with the increases in particle size with increasing reaction 
duration as measured by DLS (blue circles in Fig. 2f). It is hypothesized that TEG forms EG 
layers on the particles, which after washing allow dispersion of the particles in water. The 
cropped peak below 800 cm
-1
 can be attributed to Fe. However, a detailed FT-IR analysis below 
600 cm
-1
 was not possible in our study. The successful coating of the MNPs by alendronate is 
reflected in the change of the wide P-O and P-O-C stretching vibrational peaks between 1,150 – 
965 cm
-1
, and indicate good binding of the phosphonate to the surface of the MNPs (red line in 
Fig. 2h). In addition, the presence of a peak representing the amine group (1,650 – 1,560 cm-1) is 
found in both, free alendronate (not shown) and alendronate coated MNPs, but not pristine 
(uncoated) MNPs. This is further support that the coating was successful and that the functional 
amine group remains intact. 
In addition to FTIR characterization of the particle’s surface, the change in the isoelectric point 
of the particle sample can be used to determine the success of surface modifications. The pH 
dependent Zeta potential of pristine (uncoated) and alendronate functionalized particles was 
measured in a titration study with HCl and NaOH. At neutral pH of 7.4 pristine MNPs were 
slightly negatively charged at -7.24 mV, while alendronate particles had a surface charge of -
35.9 mV (based on linear interpolation; green squares versus red circles in Fig. 2i). The lower 
surface charge in alendronate particles was expected resulting from the highly charged 
alendronate that binds through its bisphosphonate to the MNP’s iron surface leaving a 
deprotonated hydroxyl group exposed. A shift of the isoelectric point from pH 6.8 (pristine 
MNPs) to pH 4.8 (alendronate coated MNPs) is further evidence of the successful surface 
modification of the MNPs with alendronate. This result is in good agreement with similar 
measurements of alendronate modified MNPs [31].  
To proof that the primary amines on the alendronate coating of the MNPs are available for bio-
functionalization, we conjugated rhodamine B to the alendronate MNPs through amide bonds. 
The resulting particles showed a further reduction of the particles’ charge, as expected (purple 
triangles in Fig. 2i). The particles were readily dispersed in water aided by sonication and 
remained stable in solution for a few days. The particles formed clusters of particles with average 
size measured by DLS of 249.5 ± 84.6 nm, indicating aggregation of the particles after 
functionalization.  
 
Magnetic Property Characterization 
The magnetic properties of particles synthesized at different reaction conditions were 
characterized by vibrating sample magnetometry and state of the art Superconducting Quantum 
Interference Device (SQUID) Magnetometry. SQUID was used to investigate the changes in the 
magnetic properties with varying reaction conditions. No sizeable hysteresis was observed for 
any of the samples corroborating their superparamagnetic behavior at room temperature. The 
saturation magnetization (Msat) of the particles correlated with heating duration. With increasing 
heating duration, Msat increased from 39.6 to 64.9 Am
2
/kg Fe3O4 after 30 min and 48.3 h, 
respectively (Fig. 4).  
This fact is explained by the reduction of spin canting effects at the surface due to the decrease of 
the surface area/volume ratio. In addition, an increase of the initial susceptibility with increasing 
reflux time, as the particle size increases, was observed. Similar observations were previously 
described for particles with varying core sizes [32]. 
 Figure 4.  Effect of reaction time for MNP synthesis on resulting sample magnetization (M). 
Inset shows the reaction time dependent H-M hysteresis measured by VSM for changing 
magnetic field (H). 
 
VSM measurements were used to characterize the particle size distribution from scale-up 
experiments based on the Langevin function. We found that the particle size distribution as 
measured by TEM and DSL agreed well with the size distribution calculated from the VSM 
measurements (see Fig. S1). We quantified the size and size distribution both from dried 
particles (by TEM) and in solution by dynamic light scattering and vibrating sample 
magnetometry. Based on the VSM measurements it was found that the particles were primarily 
composed of magnetite. The VSM measurements were conducted with samples obtained from 
scale-up experiments (t = 1.3 h) in a 10-fold larger reaction volume and resulted in a 18.5% 
higher Msat when compared to MNPs synthesized with the same reaction conditions, but with 2 
mL reaction volumes as measured by SQUID. It has to be noted, however, that these 
measurements were conducted by different magnetic characterization methods (VSM versus 
SQUID) and different volumes were required for each method (mL versus µL). In addition, the 
reaction volumes for the synthesis were different. Overall, the Msat values measured for the two 
reaction volumes 2 mL versus 20 mL were similar and the differences in the measurements can 
be associated with differences in methodology and associated assumptions for the Msat 
calculations. 
 
X-Ray Diffraction Analysis 
The XRD study was conducted to further support the findings from the magnetic characterization 
(by VSM and SQUID measurements) and is strong support that the MNPs contained mainly 
magnetite. The standard XRD pattern for magnetite and maghemite are shown in Fig. 5a (black 
and brown bars, respectively). It can be seen that a distinction between the two phases, magnetite 
and maghemite, is rather difficult. The XRD pattern for maghemite exhibits additional peaks that 
are not present in the XRD pattern for magnetite, albeit these peaks are small and fall below the 
detection limit of many XRD instruments. The XRD spectra from samples representing five 
different reaction conditions are shown color-coded together with a sample of alendronate coated 
MNPs (black line) in Fig. 5a. Our XRD analysis showed only peaks that could be attributed to 
magnetite or maghemite, while no peaks from other phases such as hematite or wüstite were 
detected. The characteristic peaks at (210) at 23.77° and (211) at 26.10° indicative of maghemite, 
were either not present or indistinguishable from the measurement background/noise in our XRD 
data (Fig. 5a). A closer look at characteristic peaks (400) and (511) show broader peaks with 
peak maxima correlating to those of magnetite (Fig. 5b,c). The differences in peak shift are 
particularly clear at peak (511) where the peak for magnetite is at 2θ = 57°, whereas the peak 
for maghemite is at 2θ = 57.3°. In addition, there is a decrease in peak base width with 
increasing heating duration, suggesting an increase in single-phase composition (Fig. 5a), while 
the peak center indicates primarily magnetite in all samples (see Fig. 5b and c). Furthermore, the 
use of alendronate as coating material seems not to diminish or affect the phase composition 
purely based on a comparison of the XRD spectra from coated (black line in Fig. 5a) and 
uncoated MNPs (light green line in Fig. 5a) of the same reaction duration. 
In order to overcome challenges in characterizing samples that may contain either form of iron 
oxide, Kim et al.[33] proposed a stepwise screening through two characteristic peaks (e.g., peaks 
(400) and (511)). In their work they were able to calculate the ratio of magnetite to maghemite 
based on establishing calibration curves from pure samples of the two phases. Subsequently, the 
group applied a peak deconvolution scheme to the raw data to distinguish the two peaks. 
Based on the calibration data and the peak intensity the group proposed that this method could be 
used to determine accurately the phase ratio in a sample. Although no step-wise scan around the 
peaks (400) and (511) were conducted in our study as proposed by Kim et al.[33], our XRD data 
showed only small widening peaks at the shortest reaction duration (t = 30 min), potentially 
indicating a mixed composition of magnetite and maghemite in that sample. However, such peak 
widening (blue line in Fig. 5b,c) can be an artifact of the measurement. Overall, the XRD data 
suggests that for all other reaction conditions tested the main composition of MNPs synthesized 
by our method is magnetite. 
 Figure 5. Results from the XRD and DSC studies. (a) Comparison of XRD pattern for 
samples with increasing heat duration (blue to red) to standard patterns provided by NIST for 
magnetite (black bars) and maghemite (brown bars). Also shown are the patterns for an 
alendronate-coated MNP sample after 1.3 h synthesis. Numbers in parentheses represent 
identified peaks. (b,c) Close-up comparison of two characteristic peaks indicates that the sample 
contains mainly magnetite. (d) Results from DSC Analysis for MNPs synthesized over 1.3 h. 
Shown are the heat flow curves for pristine MNPs (red curve) and MNPs coated with 
alendronate (green curve). 
 
DSC Analysis 
The endothermic heat flow shows two pronounced peaks (labeled T1 and T2 in Fig. 5d) in 
alendronate-coated MNPs, which indicate some magnetite to maghemite transition [34]. It has to 
be noted, however, that no oxygen was used for oxidation and only nitrogen flow was supplied 
during the DSC analysis. It can be speculated that the exothermic transition T1 can be associated 
to magnetite to maghemite transition at the particle surface. Alternatively, the exothermic 
transition can be a result from water evaporation from the particle’s surface or a degradation of 
the bisphosphonate coating. The transition is not present in the pristine MNPs (red line in Fig. 
5d), indicating that the surface modification with alendronate may cause the change in transition. 
However, a transitional component of magnetite/maghemite in alendronate coated MNPs was not 
found in our XRD study. This could be due to additional effects that are measurable by DSC but 
not by XRD analysis. Further studies will be required to elucidate the findings from the DSC 
analysis. However, such studies are beyond the scope of our current investigation.  
 
CONCLUSIONS 
Rapid and facile synthesis of magnetic nanoparticles is a major challenge to the development of 
magnetic drug carriers. We showed here a simple method based on a low cost iron precursor 
material (iron acetylacetonate), a green solvent (TEG), and microwave based heating to create 
magnetite MNPs with small sizes and high saturation magnetization. The MNPs showed minimal 
batch-to-batch variability, minimal variation in particle size at short reaction durations, and the 
use of polyols as solvent was found to be beneficial for minimizing toxicity of the MNPs. Our 
study showed no toxicological effect of pristine MNPs at concentrations of up to 100 g Fe / 
mL, which is comparable to similar studies using MTT assays, albeit for different cell lines used 
in those studies [30].  
The use of water miscible polyols, such as TEG, is beneficial to advance the particle synthesis 
and coating towards a truly one-pot synthetic method. Conventional methods rely on lengthy 
washing and purification steps after completion of the particle synthesis. Additional intermediate 
wet chemical steps are often required to overcome challenges in the immiscibility between 
solvents, particles, and coating materials. The use of TEG in combination with solvothermal 
synthesis resulted in small MNPs with narrow size distributions as shown by DLS and TEM 
measurements. We showed here the successful coating of MNPs directly in the solvent used to 
synthesize the MNPs. This direct coating required no sample transfer and the successful coating 
was verified by changes in the FT-IR spectra of the MNPs and by changes in the particle’s 
surface charges which is consistent with studies using similar bisphosphonate coating strategies 
[31,35]. The resulting alendronate-MNPs are functionalized, easily removed from the solvent by 
either dilution and magnetic separation or precipitation and centrifugation. 
Together with the scalability of the synthesis the method presented here is ideal for rapid high 
throughput synthesis. We showed that by increasing the reaction volume and the precursor 
concentration, the particle throughput can be scaled from milligrams to grams with high Msat. 
The scalability of the synthesis showed an increase in particle size dispersity, which can be 
attributed to the process control of the microwave synthesizer. An improvement to the 
temperature control in large glass vials used for synthesis is expected to address the dispersity 
increase with increased reaction volume, resulting in fully scalable MNP synthesis without 
changes to the MNP size distribution.  
The particles showed increasing saturation magnetization with increasing heating duration and 
were mainly composed of magnetite. The small particle size and the magnetite composition is an 
essential requirement for the use of such MNPs as magnetic drug carriers. The particles’ 
superparamagnetic behavior as shown in our magnetic characterization will minimize or 
eliminate particle agglomeration after the particles are removed from the magnetic field. This is 
of great importance for therapies in vivo to minimize the risk of arterial clogging by the magnetic 
drug carriers. The potential of a scale-up in reaction volume and particle weight is a great benefit 
to the microwave synthesis method. The reaction times investigated in this study spanned more 
than two orders of magnitude and the resulting increase in saturation magnetization (Msat) of the 
final MNPs was not linear. The greatest change Msat was observed for an increase of reaction 
time from 30 min to 1.3 h (32%) and the subsequent change in Msat falls to 3% for an increase in 
the reaction time from 22.3 h to 48.3 h. Depending on the final application of the MNPs 
synthesized by this method, the benefit of scalability of this method in green solvents can be 
paired with relative short reaction durations (i.e., few min to 1 h) and clearly show the 
advantages over conventional methods. 
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